Itamar Medical Ltd Provides Revenue Guidance for the First Quarter of 2020; Withdraws Annual Guidance for 2020
Due to the rapidly evolving global market environment and continued uncertainties resulting from the duration and impact of COVID-19, Itamar Medical is withdrawing its previously announced annual guidance for 2020, which was issued on January 13, 2020. Despite the increased demand created by the single use safety profile of the WatchPAT ONE device, which has the potential to offset the softness in Itamar Medical's multiuse device business, the Company cannot yet predict the impact of COVID-19.